MEGAN GEORGE: Open Payments
NPI 1720867781 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,947 in 75 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,678 · 2025 $1,947
Food & beverage: $1,947
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $643 |
| ABBVIE INC. | 16 | $324 |
| PFIZER INC. | 7 | $182 |
| Amgen Inc. | 5 | $114 |
| Lilly USA, LLC | 5 | $89 |
| Astellas Pharma US Inc | 3 | $81 |
| Medtronic, Inc. | 2 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
Products named: Ozempic, Wegovy, VRAYLAR, NURTEC ODT, QULIPTA, OTEZLA, REXULTI, Veozah.
Industry payments across VA — which companies pay providers there.
